Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging
Autor: | Mustafa R. Bashir, Michiie Sakamoto, Sheng Long Ye, Mengsu Zeng, Carlo Bartolozzi, Elmar M. Merkle, Claude B. Sirlin, Christoph J. Zech, Ahmed Ba-Ssalamah, Alexander Huppertz, Jens Ricke, Jeong Min Lee |
---|---|
Rok vydání: | 2016 |
Předmět: |
Adenoma
Gadolinium DTPA medicine.medical_specialty Carcinoma Hepatocellular Hepatocellular carcinoma Gadoxetic acid Clinical Sciences Contrast Media Liver mri 030218 nuclear medicine & medical imaging Adenoma Liver Cell Diagnosis Differential Cholangiocarcinoma 03 medical and health sciences 0302 clinical medicine Diagnosis Liver function tests Medicine Humans Radiology Nuclear Medicine and imaging Medical physics Magnetic Resonance Neuroradiology medicine.diagnostic_test Liver Cell business.industry Carcinoma Liver Neoplasms Magnetic resonance imaging Hepatocellular General Medicine Magnetic Resonance Imaging digestive system diseases Nuclear Medicine & Medical Imaging Radiology Nuclear Medicine and imaging Focal Nodular Hyperplasia 030220 oncology & carcinogenesis Differential Radiology business Precancerous Conditions |
Zdroj: | European radiology, vol 26, iss 3 European Radiology Merkle, EM; Zech, CJ; Bartolozzi, C; Bashir, MR; Ba-Ssalamah, A; Huppertz, A; et al.(2015). Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging. European Radiology. doi: 10.1007/s00330-015-3873-2. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/04f3p1rv |
Popis: | © 2015 The Author(s) Objectives: Liver-specific MRI is a fast-growing field, with technological and protocol advancements providing more robust imaging and allowing a greater depth of information per examination. This article reports the evidence for, and expert thinking on, current challenges in liver-specific MRI, as discussed at the 7th International Forum for Liver MRI, which was held in Shanghai, China, in October 2013. Methods: Topics discussed included the role of gadoxetic acid-enhanced MRI in the differentiation of focal nodular hyperplasia from hepatocellular adenoma and small hepatocellular carcinoma (HCC) from small intrahepatic cholangiocarcinoma (in patients with chronic liver disease), the differentiation of low-grade dysplastic nodule (DN) from pre-malignant high-grade DN and early HCC, and treatment planning and assessment of treatment response for patients with HCC and colorectal liver metastasis. Optimization of the gadoxetic acid-enhanced MRI protocol to gain robust arterial and hepatobiliary phase images was also discussed. Results and conclusions: Gadoxetic acid-enhanced MRI demonstrates added value for the detection and characterization of focal liver lesions and shows promise in a number of new indications, including regional liver functional assessment and patient monitoring after therapy; however, more data are needed in some areas, and further developments are needed to translate cutting-edge techniques into clinical practice. Key Points: • Liver-specific MRI is a fast-growing field, with many technological and protocol advancements.• Gadoxetic acid-enhanced MRI demonstrates value for detecting and characterizing focal liver lesions.• Gadoxetic acid-enhanced MRI shows promise in regional functional assessment and patient monitoring.• Further developments are needed to translate cutting-edge techniques into clinical practice. |
Databáze: | OpenAIRE |
Externí odkaz: |